These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34152033)

  • 21. Hand function and quality of life in children with epidermolysis bullosa.
    Eismann EA; Lucky AW; Cornwall R
    Pediatr Dermatol; 2014; 31(2):176-82. PubMed ID: 24274904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
    Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
    JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex.
    Brun J; Chiaverini C; Devos C; Leclerc-Mercier S; Mazereeuw J; Bourrat E; Maruani A; Mallet S; Abasq C; Phan A; Vabres P; Martin L; Bodemer C; Lagrange S; Lacour JP;
    Orphanet J Rare Dis; 2017 Jun; 12(1):119. PubMed ID: 28659151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of an epidermolysis bullosa family/parental burden score.
    Dufresne H; Hadj-Rabia S; Taieb C; Bodemer C
    Br J Dermatol; 2015 Dec; 173(6):1405-10. PubMed ID: 26281012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.
    Frew JW; Martin LK; Nijsten T; Murrell DF
    Br J Dermatol; 2009 Dec; 161(6):1323-30. PubMed ID: 19681875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.
    Wally V; Reisenberger M; Kitzmüller S; Laimer M
    Orphanet J Rare Dis; 2020 Oct; 15(1):292. PubMed ID: 33076941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling trial burden and patients' attitudes to improve clinical research in epidermolysis bullosa.
    Prodinger C; Diem A; Ude-Schoder K; Piñón-Hofbauer J; Kitzmueller S; Bauer JW; Laimer M
    Orphanet J Rare Dis; 2020 Jul; 15(1):182. PubMed ID: 32650809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Living in dressings and bandages: findings from workshops with people with Epidermolysis bullosa.
    Grocott P; Blackwell R; Weir H; Pillay E
    Int Wound J; 2013 Jun; 10(3):274-84. PubMed ID: 22487531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
    Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
    J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wound culture isolated antibiograms and caregiver-reported skin care practices in children with epidermolysis bullosa.
    Singer HM; Levin LE; Garzon MC; Lauren CT; Planet PJ; Kittler NW; Whittier S; Morel KD
    Pediatr Dermatol; 2018 Jan; 35(1):92-96. PubMed ID: 29105824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Instrument for scoring clinical outcome of research for epidermolysis bullosa: a consensus-generated clinical research tool.
    Schwieger-Briel A; Chakkittakandiyil A; Lara-Corrales I; Aujla N; Lane AT; Lucky AW; Bruckner AL; Pope E
    Pediatr Dermatol; 2015; 32(1):41-52. PubMed ID: 24650374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a Psychodermatological Education Package on the Subjective Distress, Family Burden, and Quality of Life among the Primary Caregivers of Children Affected with Epidermolysis Bullosa.
    Manomy PA; Yenamandra VK; Dabas G; Joshi P; Ambekar A; Sreenivas V; Sharma VK; Vatsa M; Ravindran S; Sethuraman G
    Indian Dermatol Online J; 2021; 12(2):276-280. PubMed ID: 33959524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study.
    Schräder NHB; Gorell ES; Stewart RE; Duipmans JC; Harris N; Perez VA; Tang JY; Wolff AP; Bolling MC
    Orphanet J Rare Dis; 2021 Sep; 16(1):377. PubMed ID: 34488820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The psychosocial impact of chronic wounds on patients with severe epidermolysis bullosa.
    Adni T; Martin K; Mudge E
    J Wound Care; 2012 Nov; 21(11):528, 530-6, 538. PubMed ID: 23413491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
    Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting quality of life in epidermolysis bullosa.
    Pagliarello C; Tabolli S
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):329-38. PubMed ID: 20545597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited epidermolysis bullosa: new diagnostic criteria and classification.
    Intong LR; Murrell DF
    Clin Dermatol; 2012; 30(1):70-7. PubMed ID: 22137229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of inherited epidermolysis bullosa in Romania and genotype-phenotype correlations in patients with dystrophic epidermolysis bullosa.
    Dănescu S; Has C; Senila S; Ungureanu L; Cosgarea R
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):899-903. PubMed ID: 25201089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of topical morphine gel in epidermolysis bullosa wounds-A series of case studies.
    Snelson K; Downe A
    Int Wound J; 2023 Aug; 20(6):1954-1959. PubMed ID: 36517963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.